{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T22:41:49Z","timestamp":1769726509469,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2013\/20479-9"],"award-info":[{"award-number":["2013\/20479-9"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.tube.2016.04.002","type":"journal-article","created":{"date-parts":[[2016,4,10]],"date-time":"2016-04-10T06:55:02Z","timestamp":1460271302000},"page":"11-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Antimycobacterial activity of pyrazinoate prodrugs in replicating and non-replicating Mycobacterium tuberculosis"],"prefix":"10.1016","volume":"99","author":[{"given":"Natanael Dante","family":"Segretti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina Kortstee","family":"Sim\u00f5es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle Fidelis","family":"Corr\u00eaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veni Maria Andres","family":"Felli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Hyun","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott Gary","family":"Franzblau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9089-273X","authenticated-orcid":false,"given":"Jo\u00e3o Paulo dos Santos","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2016.04.002_bib1","series-title":"Global tuberculosis report 2014","author":"WHO, World Health Organization","year":"2014"},{"key":"10.1016\/j.tube.2016.04.002_bib2","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jsps.2013.12.005","article-title":"Synthesis and evaluation of a pyrazinoic acid prodrug in Mycobacterium tuberculosis","volume":"22","author":"Fernandes","year":"2013","journal-title":"Saudi Pharm J"},{"key":"10.1016\/j.tube.2016.04.002_bib3","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1128\/AAC.00055-06","article-title":"Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis","volume":"51","author":"Cho","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2016.04.002_bib4","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1021\/jm900003c","article-title":"Structure-activity relationships for a series of quinoline-based compounds active against replicating and nonreplicationg Mycobacterium tuberculosis","volume":"52","author":"Lilienkampf","year":"2009","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.tube.2016.04.002_bib5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/jac\/dkn214","article-title":"In\u00a0vitro and in\u00a0vivo antimycobacterial activities of ketone and amide derivatives of quinoxaline 1,4-di-N-oxide","volume":"62","author":"Villar","year":"2008","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.tube.2016.04.002_bib6","doi-asserted-by":"crossref","first-page":"7274","DOI":"10.1016\/j.bmc.2010.08.016","article-title":"Synthesis of non-purine analogs of 6-aryl-9-benzylpurines, and their antimycobacterial acitivies. Compounds modified in the imidazole ring","volume":"18","author":"Khoje","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.tube.2016.04.002_bib7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejmech.2013.11.007","article-title":"Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents","volume":"72","author":"Pieroni","year":"2014","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.tube.2016.04.002_bib8","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/jac\/dkg446","article-title":"Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid","volume":"52","author":"Zhang","year":"2003","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.tube.2016.04.002_bib9","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1016\/j.bmcl.2011.06.055","article-title":"Pyrazinamide, but not pyrazinoic acid, is a competitive inhibitor of NADPH binding to Mycobacterium tuberculosis fatty acid synthase I","volume":"21","author":"Sayahi","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.tube.2016.04.002_bib10","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1021\/jm00085a007","article-title":"Antimycobacterial activity of a series of pyrazinoic acid-esters","volume":"35","author":"Cynamon","year":"1992","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.tube.2016.04.002_bib11","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1021\/jm00020a003","article-title":"Pyrazinoic acid-esters with broad-spectrum in-vitro antimycobacterial activity","volume":"38","author":"Cynamon","year":"1995","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.tube.2016.04.002_bib12","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1021\/jm950538t","article-title":"Quantitative structure-activity relationships for the in\u00a0vitro antimycobacterial activity of pyrazinoic acid esters","volume":"39","author":"Bergmann","year":"1996","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.tube.2016.04.002_bib13","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1590\/S0100-40422009000900040","article-title":"Evaluation of the influence of base and alkyl bromide on synthesis of pyrazinoic acid esters through fatorial design","volume":"32","author":"Fernandes","year":"2009","journal-title":"Quim Nova"},{"key":"10.1016\/j.tube.2016.04.002_bib14","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1128\/AAC.41.5.1004","article-title":"Microplate Alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium","volume":"41","author":"Collins","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2016.04.002_bib15","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1128\/AAC.04054-14","article-title":"The cyclic peptide ecumicin targeting ClpC1 is active against Mycobacterium tuberculosis in\u00a0vivo","volume":"59","author":"Gao","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2016.04.002_bib16","series-title":"Marvin version 14.8.11","author":"Chemaxon Inc","year":"2014"},{"key":"10.1016\/j.tube.2016.04.002_bib17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1021\/ci00063a006","volume":"29","author":"Viswanadhan","year":"1989","journal-title":"J\u00a0Chem Inf Comput Sci"},{"key":"10.1016\/j.tube.2016.04.002_bib18","series-title":"The practice of medicinal chemistry","first-page":"721","article-title":"Designing prodrugs and bioprecursors","author":"Wermuth","year":"2008"},{"key":"10.1016\/j.tube.2016.04.002_bib19","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3390\/molecules13030616","article-title":"Prodrugs for treatment of neglected diseases","volume":"13","author":"Chung","year":"2008","journal-title":"Molecules"},{"key":"10.1016\/j.tube.2016.04.002_bib20","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.tube.2012.07.003","article-title":"Comprehensive analysis of methods used for the evaluation of compounds against Mycobacterium tuberculosis","volume":"92","author":"Franzblau","year":"2012","journal-title":"Tuberculosis"},{"key":"10.1016\/j.tube.2016.04.002_bib21","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1128\/AAC.06288-11","article-title":"Targeting persisters for tuberculosis control","volume":"56","author":"Zhang","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2016.04.002_bib22","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1128\/AAC.39.6.1269","article-title":"Activity of n-propyl pyrazinoate against pyrazinamide-resistant Mycobacterium tuberculosis: investigations into mechanism of action of and mechanism of resistance to pyrazinamide","volume":"39","author":"Speirs","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2016.04.002_bib23","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1128\/AAC.42.2.462","article-title":"In\u00a0vitro antimycobacterial activity of 5-chloropyrazinamide","volume":"42","author":"Cynamon","year":"1998","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979215301177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979215301177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:39:48Z","timestamp":1761467988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979215301177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":23,"alternative-id":["S1472979215301177"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2016.04.002","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimycobacterial activity of pyrazinoate prodrugs in replicating and non-replicating Mycobacterium tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2016.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}